Home | Repositories | Statistics | About



Subject: hepatitis C virus infection,
Subject: statins,
Subject: pegylated interferon alpha,
Subject: ribavirin,
Subject: sustained virological response


Year: 2019


Type: Article



Title: Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus


Author: Beti Todorovska
Author: Caloska Ivanova, Viktorija
Author: Genadieva Dimitrova, Magdalena
Author: Trajkovska, Meri
Author: Popova Jovanovska, Rozalinda
Author: Grivceva-Stardelova, Kalina
Author: Lichoska Josifovikj, Fana
Author: Andreevski, Vladimir
Author: Curakova Ristovska, Elena
Author: Joksimovic, Nenad



Abstract: Chronic hepatitis C virus infection represents a more frequent cause of liver cirrhosis and hepatocellular carcinoma. Statins, inhibit HCV replication in vitro, enhance the antiviral effect of the already known antiviral drugs and reduce their resistance.


Publisher: ID Design 2012/Scientific Foundation SPIROSKI


Relation: Open Access Macedonian Journal of Medical Sciences



Identifier: oai:repository.ukim.mk:20.500.12188/8932
Identifier: 1857-9655
Identifier: http://hdl.handle.net/20.500.12188/8932
Identifier: 10.3889/oamjms.2019.459
Identifier: https://spiroski.migration.publicknowledgeproject.org/index.php/mjms/article/download/oamjms.2019.459/3384
Identifier: 7
Identifier: 10



TitleDateViews
Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus201935